MABs
5 Skills for Navigating the Pandemic With EUA Therapies
Specialty and infusion pharmacies have been playing a critical role in making a frequently changing menu of infused ...
JULY 15, 2022
FDA Limits Use of Monoclonal Antibodies to Treat COVID-19
The FDA revised the EUAs for two monoclonal antibody cocktails for COVID-19, essentially saying the should not be ...
JANUARY 25, 2022
Pharmacists Authorized to Order and Administer COVID-19 Therapeutics Under PREP Act Declaration
An amendment to the PREP Act broadly addresses the pharmacist's role in providing COVID-19 therapeutics, including ...
SEPTEMBER 17, 2021
FDA Authorizes Baricitinib Alone as COVID-19 Treatment
The FDA revised the emergency use authorization (EUA) for baricitinib to enable its use alone for the treatment of ...
JULY 29, 2021
FDA Revokes EUA for Bamlanivimab Monotherapy for COVID-19; Still Authorized in Combination
Although the FDA revoked its EUA for bamlanivimab monotherapy, the agency said it could still be given ...
APRIL 21, 2021
